Induction of circulating T follicular helper cells and regulatory T cells correlating with HIV-1 gp120 variable loop antibodies by a subtype C prophylactic vaccine tested in a Phase I trial in India

PloS One
Sivasankaran Munusamy PonnanHanna Elizabeth Luke

Abstract

A Phase I HIV-1 vaccine trial sponsored by the International AIDS Vaccine Initiative (IAVI) was conducted in India in 2009 to test a subtype C prophylactic vaccine in a prime-boost regimen comprising of a DNA prime (ADVAX) and MVA (TBC-M4) boost. The trial demonstrated that the regimen was safe and well tolerated and resulted in enhancement of HIV-specific immune responses. Preliminary observations on vaccine-induced immune responses were limited to analysis of neutralizing antibodies and IFN-γ ELISPOT response. The present study involves a more detailed analysis of the nature of the vaccine-induced humoral immune response using specimens that were archived from the volunteers at the time of the trial. Interestingly, we found vaccine induced production of V1/V2 and V3 region-specific antibodies in a significant proportion of vaccinees. Variable region antibody levels correlated directly with the frequency of circulating T follicular helper cells (Tfh) and regulatory T cells (Treg). Our findings provide encouraging evidence to demonstrate the immunogenicity of the tested vaccine. Better insights into vaccine-induced immune responses can aid in informing future design of a successfulHIV-1 vaccine.

References

Nov 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·P SchaerliB Moser
Mar 21, 2003·Nature·Xiping WeiGeorge M Shaw
Mar 24, 2004·Seminars in Immunology·Clare Baecher-AllanDavid A Hafler
Mar 24, 2004·Seminars in Immunology·Kingston H G Mills, Peter McGuirk
Aug 6, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Barry T Rouse, Susmit Suvas
Nov 2, 2004·Nature Reviews. Immunology·Kingston H G Mills
Sep 26, 2007·Immunity·Thomas Dörner, Andreas Radbruch
Jul 26, 2008·Science·Anthony S FauciWarner C Greene
Feb 15, 2011·Annual Review of Immunology·Shane Crotty
Nov 8, 2011·Methods in Molecular Biology·Haibin SuYun Ma
Dec 29, 2011·Current HIV/AIDS Reports·Ann J Hessell, Nancy L Haigwood
Apr 6, 2012·The New England Journal of Medicine·Barton F HaynesJerome H Kim
May 30, 2012·The Journal of Experimental Medicine·Laura E McCoyRobin A Weiss
Jul 4, 2012·The Journal of Experimental Medicine·Cindy S MaStuart G Tangye
Aug 28, 2012·The Journal of Clinical Investigation·Constantinos PetrovasRichard A Koup
Oct 23, 2012·Frontiers in Immunology·Denise A KaminskiIgnacio Sanz
Jan 22, 2013·Annual Review of Immunology·Davide Corti, Antonio Lanzavecchia
Feb 8, 2013·Nature Medicine·Hendrik StreeckShane Crotty
Mar 15, 2013·Science Translational Medicine·Salah-Eddine BentebibelHideki Ueno
Apr 5, 2013·Nature·Hua-Xin LiaoBarton F Haynes
Jul 23, 2013·Retrovirology·Torben SchiffnerLucy Dorrell
Aug 3, 2013·Frontiers in Immunology·Federico Simonetta, Christine Bourgeois
Nov 7, 2013·Current HIV Research·Mangala RaoVenigalla B Rao
Apr 8, 2014·Trends in Immunology·Franco Pissani, Hendrik Streeck
Aug 29, 2014·Expert Review of Vaccines·Robert J O'ConnellJean-Louis Excler
Oct 14, 2014·Frontiers in Microbiology·Jorjoh Ndure, Katie L Flanagan
Oct 29, 2014·Proceedings of the National Academy of Sciences of the United States of America·George K LewisRobert C Gallo

❮ Previous
Next ❯

Citations

Mar 16, 2019·Immunological Reviews·Wenzhi Song, Joe Craft

❮ Previous
Next ❯

Methods Mentioned

BETA
IEC
ELISA
FACS
flow cytometry

Software Mentioned

GraphPad
FlowJo
GraphPad Prism

Related Concepts

Related Feeds

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.